Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan. [PDF]
Matsui H +11 more
europepmc +1 more source
ZAP-70 and Bcl-2 expression in B lymphoblastic leukemia cells and hematogones
Urvashi Surti +3 more
core +1 more source
CD38 and CD58: A Gallant Savior in Under-Resourced Laboratories. [PDF]
Agarwal A +5 more
europepmc +1 more source
False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience). [PDF]
Korkina YS +6 more
europepmc +1 more source
Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. [PDF]
Jum'ah HA +8 more
europepmc +1 more source
Microfluidic Affinity Selection of B-Lineage Cells from Peripheral Blood for Minimal Residual Disease Monitoring in Pediatric B-Type Acute Lymphoblastic Leukemia Patients. [PDF]
Witek MA +8 more
europepmc +1 more source
How I treat postimmunotherapy relapsed B-ALL.
Lamble AJ, Kovach AE, Shah NN.
europepmc +1 more source
Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen. [PDF]
Al-Aghbri SMA +3 more
europepmc +1 more source
Deep learning model for early acute lymphoblastic leukemia detection using microscopic images. [PDF]
Anand V, Bachhal P, Koundal D, Dhaka A.
europepmc +1 more source

